Grundinformationen
- Standard-SMILES
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1=O- InChIKey
GGCUJPCCTQNTJF-FRCNGJHJSA-N- Summenformel
- C20H26O3
- Durchschnittliche Molmasse
- 314,4 g/mol
- Monoisotopische Masse
- 314,18819469
Namen und Bezeichner
- Bevorzugter Name
- 4-Oxoretinoic acid
- IUPAC
- (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
- Englischer Name
- (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxo-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid
- Summenformel
- C20H26O3
- Molmasse
- 314.42
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
38030-57-8- PubChem CID
- 6437063
- DTXSID
DTXSID20865895- ChEMBL
CHEMBL104049- ChEBI
CHEBI:80656- UNII
- CJN45G18UA
- EC Number
- 996-032-6
- Nikkaji
- J362.532J
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 4,8
- Polarare Oberfläche (TPSA)
- 54,4 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 5
- Schwere Atome
- 23
- Formalladung
- 0
- Komplexität
- 638
Experimentelle und physikochemische Eigenschaften
Physikochemische Eigenschaften
- Schmelzpunkt
- 175 · 175-179 °C
- Siedepunkt
- 509.9 · 509.9±29.0 °C(Predicted)
- Dichte
- 1.07 · 1.070±0.06 g/cm3(Predicted)
- storage temp.
- -20 °C · Amber Vial, -20°C Freezer, Under Inert Atmosphere
- Löslichkeit
- Chloroform (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 4.73 · 4.73±0.33(Predicted)
- Farbe
- Yellow to Dark Orange
- Stabilität
- -20 °C · Store Dry in Freezer at -20°C for up to 1 year; in Solution at -20°C for up to 3 Months.
- Major Application
- clinical testing
- InChI
- InChI=1S/C20H26O3/c1-14(7-6-8-15(2)13-19(22)23)9-10-17-16(3)18(21)11-12-20(17,4)5/h6-10,13H,11-12H2,1-5H3,(H,22,23)/b8-6+,10-9+,14-7+,15-13+
- InChIKey
- GGCUJPCCTQNTJF-FRCNGJHJSA-N
- SMILES
- C(O)(=O)/C=C(/C=C/C=C(/C=C/C1C(C)(C)CCC(=O)C=1C)\C)\C
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (50%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (50%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H360D (50%): May damage the unborn child [Danger Reproductive toxicity];H361fd (50%): Suspected of damaging fertility; Suspected of damaging the unborn child [Warning Reproductive toxicity]
P203, P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Sicherheitsdaten
- wgk
- WGK 3
- Speicherklasse
- 11 - Combustible Solids
- Hazard Classifications
- Repr. 2
Chemie und Industrie
Pharmakologische Informationen
Anwendungen
VerwendenA metabolite of all-trans-Retinoic Acid, a ligand for both the retinoic acid receptor (RAR) and the retinoid X receptor (RXR).
Anbieter50 Anbieter
Ergänzende Hinweise
DefinitionChEBI: A retinoid that consists of all-trans-retinoic acid bearing an oxo substituent at position 4 on the cyclohexenyl ring.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…